
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
Corvia Medical, Inc. is revolutionizing the treatment of heart failure with a novel transcatheter structural heart device. Founded in 2009 and headquartered in Tewksbury, MA, Corvia Medical is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives. The Corvia Atrial Shunt is the worlds first transcatheter device approved by the European Union to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction. Privately held, the company is backed by Third Rock Ventures, General Catalyst Partners, AccelMed, and Lumira Ventures, Edward Lifesciences and an undisclosed strategic investor. In the United States,...
Medical device,hfpef,hfref,heart failure,congestive heart failure,interventional cardiology,structural heart,heart failure with preserved ejection fraction,heart failure with reduced ejection fraction,and hfmref
Corvia medical, inc operates in the Medical equipment manufacturing industry.
Corvia medical, inc's revenue is 11m - 100m
Corvia medical, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.